Business Context and Reporting Period
Company: Richardson Electronics, Ltd. (RELL)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Second quarter of fiscal 2026 ended November 29, 2025 (13 weeks).
Business Overview: A global manufacturer of engineered solutions, green energy products, power grid/microwave tubes, and customized display solutions. The company serves markets including alternative energy, healthcare, aviation, and semiconductors.
Segment Restructuring: Effective June 1, 2025, the company realigned from four to three reportable segments: Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. The former Healthcare segment was largely sold to DirectMed Imaging, LLC, with Richardson retaining an exclusive supply agreement for CT tubes.
Key Financial Metrics
| Metric (in thousands) | Q2 FY26 (3 Months) | Q2 FY25 (3 Months) | YTD FY26 (6 Months) | YTD FY25 (6 Months) |
|---|---|---|---|---|
| Net Sales | $52,288 | $49,491 | $106,895 | $103,216 |
| Gross Profit | $16,077 | $15,326 | $33,006 | $31,752 |
| Gross Margin % | 30.8% | 31.0% | 30.9% | 30.8% |
| Operating Income (Loss) | $132 | $(667) | $1,100 | $(351) |
| Net Income (Loss) | $(121) | $(751) | $1,788 | $(161) |
| Diluted EPS (Common) | $(0.01) | $(0.05) | $0.12 | $(0.01) |
| Cash & Equivalents (End of Period) | $33,138 | $26,635 | $33,138 | $26,635 |
| Operating Cash Flow (YTD) | $1,268 | $5,877 | ||
| Free Cash Flow (YTD) | ||||
| Total Debt (Revolving Credit) | $0 (No borrowings outstanding) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 5.7% in Q2 and 3.6% YTD compared to the prior year. Growth was driven by the GES segment (+39.0% Q2, +10.7% YTD) and Canvys segment (+28.1% Q2, +17.7% YTD), partially offset by a decline in the PMT segment (-4.0% Q2, -0.5% YTD) due to reduced Healthcare product sales following the asset sale.
- Profitability Turnaround: The company returned to profitability on a YTD basis, reporting net income of $1.8 million compared to a net loss of $0.2 million in the prior year. Q2 operating income improved from a loss of $0.7 million to a profit of $0.1 million.
- Non-Recurring Items: YTD results included a non-recurring gain of $0.9 million classified under "Other, net," significantly impacting the bottom line.
- Foreign Exchange: Foreign exchange losses were $0.5 million in Q2 and $0.2 million YTD, impacting operating results.
- Working Capital: Accounts receivable increased by $3.2 million YTD, and inventories increased by $1.5 million YTD, reflecting higher sales levels and production activity.
Guidance, Outlook, and Risks
- Outlook: Management believes existing liquidity sources and operating cash flows will satisfy obligations for the next 12 months. No specific forward-looking financial guidance (e.g., revenue targets) was provided in this filing.
- Capital Resources: On October 7, 2025, the company extended its revolving credit facility with PNC Bank for three years (maturing October 2028) with a $20 million limit. No amounts were drawn as of November 29, 2025.
- Dividends: The company paid cash dividends of $0.060 per share on Common Stock and $0.054 per share on Class B Common Stock for the quarter.
- Risks:
- Trade Policy: Exposure to tariffs and trade protection measures, particularly regarding imports into the U.S. and exports to other countries.
- Geopolitical: Risks related to armed conflicts in Europe and the Middle East affecting global business disruption.
- Currency: Significant exposure to foreign currency exchange fluctuations as operations are global.
- Customer Concentration: Reliance on specific markets (e.g., semiconductor, healthcare) and the transition of the Healthcare business to a supply agreement model.
- Unusual Items: Implementation of a new General Ledger system in Q2 FY26 to enhance efficiency.
Investor Verification Checklist
- Segment Mix Impact: Verify the sustainability of growth in GES and Canvys segments versus the structural decline in PMT due to the Healthcare asset sale.
- Non-Recurring Gains: Assess the $0.9 million "Other, net" gain included in YTD income to determine core operating profitability.
- Working Capital Trends: Monitor the increase in Accounts Receivable and Inventory to ensure collection rates and inventory turnover remain healthy.
- Tax Rate Volatility: Review the effective tax rate (16.2% YTD) which varies based on the geographical distribution of income and utilization of R&D credits.
- Dividend Coverage: Confirm that operating cash flows remain sufficient to support the quarterly dividend policy amidst working capital fluctuations.